Daré Bioscience, Inc. (DARE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 215.75M |
| Enterprise Value | 193.69M |
| P/E Ratio | -1.97 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 16.87 |
| Price/Book Ratio | 40.54 |
| Enterprise/Revenue | 2.26 |
| Enterprise/EBITDA | -0.27 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -10.39 |
| Operating Margin | -10.34 |
| Return On Assets | -0.43 |
| Return On Equity | 7.63 |
| Revenue | 1.03M |
| Revenue/Share | 0.08 |
| Gross Profit | -1.42M |
| EBITDA | -10.43M |
| Net Income | -13.4M |
| Diluted EPS | -1.2 |
| Total Cash | 18.52M |
| Total Cash/Share | 1.28 |
| Total Debt | 1.61M |
| Total Debt/Equity | 2.2 |
| Current Ratio | 1.03 |
| Book Value Per Share | 0.05 |
| 52-Week Change | -19.92 |
| 52-Week High | 9.19 |
| 52-Week Low | 1.27 |
| Moving Average 50 Days | 2.3 |
| Moving Average 200 Days | 1.99 |
| Average Volume | 635,151 |
| Shares Outstanding | 9.52M |
| % Held by Institutions | 7.07 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | July 01, 2024 |